implanted fiducial-based imaging

PROCEDURE4 trials

Sponsors

Case Comprehensive Cancer Center, Virginia Commonwealth University, Mayo Clinic, Institute of Cancer Research, United Kingdom

Conditions

Bladder CancerLung CancerProstate CancerUnspecified Adult Solid Tumor

Phase 1

Implantation of Markers for the Radiotherapy of Lung Cancer Patients

TerminatedNCT00856427

Virginia Commonwealth UniversityLung Cancer

Start: 2008-02-29End: 2012-08-31Updated: 2013-12-20

Stereotactic Radiation Therapy in Treating Patients With Liver Metastases

TerminatedNCT00938457

Mayo ClinicUnspecified Adult Solid Tumor

Start: 2009-07-31Updated: 2016-05-19

3-Dimensional Conformal Radiation Therapy in Treating Patients With Bladder Cancer Who Have Undergone Transurethral Resection of the Bladder

Institute of Cancer Research, United KingdomBladder Cancer

Start: 2009-05-31Target: 60Updated: 2013-08-26

Unknown Phase

Stereotactic Radiation Therapy in Treating Patients With Prostate Cancer

TerminatedNCT00619515

Case Comprehensive Cancer CenterProstate Cancer

Start: 2007-12-31End: 2013-02-28Updated: 2019-08-22

Related Papers

Bladder Tumor-Focused Adaptive Radiation Therapy: Clinical Outcomes of a Phase I Dose Escalation Study

International Journal of Radiation Oncology*Biology*Physics2024-07-273 citations

Protocol for tumour-focused dose-escalated adaptive radiotherapy for the radical treatment of bladder cancer in a multicentre phase II randomised controlled trial (RAIDER): radiotherapy planning and delivery guidance

BMJ Open2020-12-0134 citations

Prospective phase 1 study assessing feasibility of IMRT and IGART to deliver simultaneous integrated high-dose tumor boost (up to 70 Gy) for the radical treatment of localized muscle-invasive bladder cancer.

Journal of Clinical Oncology2015-03-01